Immunome compensation committee grants inducement under Nasdaq Rule 5635(c)(4)
Immunome, Inc. said its Compensation Committee approved inducement grants under Nasdaq Listing Rule 5635(c)(4) on September 1, 2026.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.